Driven by increasing consumer demand, the emergence of innovative technologies, and a shift to value-based care, digital health products and services are disrupting the global healthcare landscape at a rapid pace.
Morgan Lewis advises clients involved in the digital health sector on the full spectrum of novel and evolving legal, business, privacy, regulatory, and policy challenges they confront. Our clients include startups, venture capital and private equity firms, healthcare providers, health insurers, trade associations, consumer electronics, medical devices, pharmaceuticals, biotech, telecommunications, and technology companies.
Our lawyers help navigate clients through US Food and Drug Administration (FDA) regulation, privacy and cybersecurity concerns, reimbursement matters, Federal Communications Commission (FCC) and telecommunications regulation, state regulations, intellectual property matters, and transactions related to government contracts, venture capital, financing, mergers and acquisitions, and initial public offerings (IPOs), among other matters.
Our team, which includes more than 200 lawyers with experience in the healthcare, technology and life sciences sectors, advises clients across the digital health landscape, including companies focusing on the following areas: